Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma.
Overview
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming 650201, China
- Hangzhou Xiaoshan Donghai Aquaculture Co. Ltd. Hangzhou 311200, China; (Q.Y.); (X.Z.); (Y.C.)
- Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, 110 Xiangya Road, Changsha 410078, China
Abstract
Gliomas are aggressive brain tumors with poor prognosis. The contribution of Toxoplasma gondii (T. gondii)-related transcriptional programs to glioma remains unclear. We identified T. gondii infection-related genes from neuroepithelial cell transcriptomes, mapped them to TCGA and CGGA glioma datasets, and validated their expression via RT-qPCR. A prognostic signature (TGRisk) was constructed via Cox and LASSO regression and validated across independent cohorts. Functional, immune, and drug sensitivity analyses were conducted. Forty infection-related genes were identified, enriched in stress responses, microRNA regulation, ribosome biogenesis, and metabolism. The 13-gene TGRisk model significantly separated survival between high- and low-risk groups. A nomogram combining TGRisk with clinical features improved prediction accuracy. High-risk tumors showed immune activation and higher infiltration of CD8+ T cells, Tregs, macrophages, and neutrophils, while low-risk tumors showed enhanced neuronal signaling and NK cell activity. Drug sensitivity prediction suggested low-risk patients were more responsive to temozolomide and bortezomib, whereas high-risk patients were more sensitive to dasatinib and ruxolitinib. We developed a novel T. gongdii infection-related gene signature that stratifies glioma patients by prognosis, immune features, and therapeutic vulnerabilities. These findings suggest host–T. gondii interactions and a potential biomarker for patient stratification and personalized therapy.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE22986, at NCBI GEO; found in “Data Availability Statement”
Data Availability Statement
The datasets supporting the conclusions of this study are publicly available. TCGA data can be accessed via https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 4 keywords, 1 funder, 47 references.
Cite
This paper
Pan, L., Hu, Q., Yu, Q., Zhang, X., Chen, Y., Chen, F., & Deng, W. (2026). Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma. Biology, 15(8), 633. https://
BibTeX
@article{pan2026developm
author = {Pan, Le and Hu, Qian and Yu, Qili and Zhang, Xueyu and Chen, Yangfei and Chen, Fei and Deng, Weidong},
title = {{Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma}},
journal = {Biology},
year = {2026},
month = apr,
volume = {15},
number = {8},
pages = {633},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2079-7737},
doi = {10.3390/
url = {https://
pmid = {42041911},
pmcid = {PMC13113236}
}
RIS
TY - JOUR
AU - Pan, Le
AU - Hu, Qian
AU - Yu, Qili
AU - Zhang, Xueyu
AU - Chen, Yangfei
AU - Chen, Fei
AU - Deng, Weidong
TI - Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma
T2 - Biology
J2 - Biology (Basel)
PY - 2026
DA - 2026/
VL - 15
IS - 8
SP - 633
SN - 2079-7737
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3390/
"type": "article-journal",
"title": "Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma",
"container-title": "Biology",
"author": [
{
"family": "Pan",
"given": "Le"
},
{
"family": "Hu",
"given": "Qian"
},
{
"family": "Yu",
"given": "Qili"
},
{
"family": "Zhang",
"given": "Xueyu"
},
{
"family": "Chen",
"given": "Yangfei"
},
{
"family": "Chen",
"given": "Fei"
},
{
"family": "Deng",
"given": "Weidong"
}
],
"container-title-short":
"volume": "15",
"issue": "8",
"page": "633",
"DOI": "10.3390/
"PMID": "42041911",
"PMCID": "PMC13113236",
"ISSN": "2079-7737",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
17
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13578-024-01218-4 [code]
- Revealing the role of SPP1<sup>+</
sup> macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas. Journal: Cell & bioscienceIn common: clinical / translational, other condition, 6 references - [2] doi:10.1007/s00262-025-04206-w
- Integrative analysis of single-cell and bulk transcriptome data reveals age-related immune cell alterations in primary glioblastoma associated with prognosis.Journal: Cancer immunology, immunotherapy : CIIIn common: other condition, 5 references
- [3] doi:10.1111/jcmm.18339
- Multi-omics analysis reveals the association between specific solute carrier proteins gene expression patterns and the immune suppressive microenvironment in glioma.Journal: Journal of cellular and molecular medicineIn common: other condition, 5 references
- [4] doi:10.1186/s12967-026-08397-3
- FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-κB/
IL-6 signaling pathway. Journal: Journal of translational medicineIn common: other condition, 4 references - [5] doi:10.3389/fcimb.2023.1267629
- Multiomics and bioinformatics identify differentially expressed effectors in the brain of <i>Toxoplasma gondii</
i> infected masked palm civet. Journal: Frontiers in cellular and infection microbiologyIn common: other condition, 3 references - [6] doi:10.1371/journal.ppat.1012733
- Toxoplasma gondii infection of neurons alters the production and content of extracellular vesicles directing astrocyte phenotype and contributing to the loss of GLT-1 in the infected brain.Journal: PLoS pathogensIn common: other condition, 3 references
- [7] doi:10.1007/s12672-025-03557-1
- Immunogenic cell death-related macrophage gene model for prognostic prediction in glioblastoma.Journal: Discover oncologyIn common: other condition, 4 references
- [8] doi:10.1186/s40478-023-01613-x
- Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis.Journal: Acta neuropathologica communicationsIn common: other condition, 4 references
- [9] doi:10.3389/fimmu.2024.1494806
- ScRNA-seq unveils the functional characteristics of glioma-associated macrophages and the regulatory effects of chlorogenic acid on the immune microenvironment-a study based on mouse models and clinical practice.Journal: Frontiers in immunologyIn common: other condition, 4 references
- [10] doi:10.3389/fimmu.2023.1238684
- The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.Journal: Frontiers in immunologyIn common: other condition, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
